Pages that link to "Q24677386"

The following pages link to The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer (Q24677386):

Displaying 50 items.

• NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily (Q22008826) ‎ (← links)
• Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells (Q22010576) ‎ (← links)
• Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity (Q24310824) ‎ (← links)
• Polymorphism and domain variability of human killer cell inhibitory receptors (Q24329103) ‎ (← links)
• Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells (Q24671834) ‎ (← links)
• The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity (Q27641400) ‎ (← links)
• KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A * 11 while diminishing avidity for HLA-C (Q27657994) ‎ (← links)
• Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11 (Q27681802) ‎ (← links)
• Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual (Q28116391) ‎ (← links)
• N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors (Q28143398) ‎ (← links)
• Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors (Q28199747) ‎ (← links)
• Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands (Q28206287) ‎ (← links)
• Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma (Q28210382) ‎ (← links)
• Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors (Q28259065) ‎ (← links)
• Human diversity in killer cell inhibitory receptor genes (Q28259075) ‎ (← links)
• HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors (Q28298119) ‎ (← links)
• Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas (Q28364322) ‎ (← links)
• Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells (Q28610389) ‎ (← links)
• A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors (Q28610391) ‎ (← links)
• Immunogenetics as a tool in anthropological studies (Q28740417) ‎ (← links)
• Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells (Q28743223) ‎ (← links)
• Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. (Q28754594) ‎ (← links)
• Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors (Q28776435) ‎ (← links)
• Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses (Q32064770) ‎ (← links)
• Association of HLA-B*51:01 with papillary thyroid carcinoma in the Chinese Han population of the Shandong coastal areas (Q33632666) ‎ (← links)
• Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR). (Q33672480) ‎ (← links)
• Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells (Q33682268) ‎ (← links)
• HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy (Q33785744) ‎ (← links)
• Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes (Q33789518) ‎ (← links)
• Distribution of HLA-A, -B, and -C alleles and HLA/KIR combinations in Han population in China. (Q33796633) ‎ (← links)
• Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. (Q33829858) ‎ (← links)
• HLA-class I-specific inhibitory receptors in HIV-1 infection (Q33829872) ‎ (← links)
• Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy (Q33845247) ‎ (← links)
• KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif (Q33851496) ‎ (← links)
• Cobalt-mediated dimerization of the human natural killer cell inhibitory receptor (Q33902254) ‎ (← links)
• Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans (Q33909456) ‎ (← links)
• Identification and molecular characterization of a natural mutant of the p50.2/KIR2DS2 activating NK receptor that fails to mediate NK cell triggering (Q33932618) ‎ (← links)
• Association of activating KIR copy number variation of NK cells with containment of SIV replication in rhesus monkeys (Q34109760) ‎ (← links)
• Natural killer cells and their receptors (Q34148233) ‎ (← links)
• Human natural killer cell activating receptors. (Q34277965) ‎ (← links)
• Recombinant structures expand and contract inter and intragenic diversification at the KIR locus (Q34581495) ‎ (← links)
• Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas. (Q34769861) ‎ (← links)
• KIR/HLA interactions and pathogen immunity (Q35001169) ‎ (← links)
• Influence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells (Q35104217) ‎ (← links)
• Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3. (Q35126671) ‎ (← links)
• Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes (Q35183203) ‎ (← links)
• Immunopathogenesis of cutaneous T-cell lymphomas. (Q35622801) ‎ (← links)
• HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. (Q35798486) ‎ (← links)
• HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts (Q35925041) ‎ (← links)
• KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease. (Q36094774) ‎ (← links)